Albiglutide
Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects
GSK · Phase 4 · Terminated · Enrollment 8
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Albiglutide arm | T2D only | n/r | 26 | n/r | n/r |